Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIB-PAIN: Fascia Iliaca Block for Hip Arthroplasty
NCT06534697Not yet recruiting
- Sponsor
- Foisor Orthopedics Clinical Hospital
- Start
- Jul 2024
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (3 arms), sponsored by Foisor Orthopedics Clinical Hospital. Primary endpoint: Total morphine consumption at 24 hours postoperatively. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06534697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06534697.